- Home
- LWLG vs NKTR Comparison
LWLG vs NKTR Comparison
Compare LWLG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWLG
- NKTR
- Stock Information
- Founded
- LWLG 1991
- NKTR 1990
- Country
- LWLG United States
- NKTR United States
- Employees
- LWLG N/A
- NKTR N/A
- Industry
- LWLG Containers/Packaging
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- LWLG Industrials
- NKTR Health Care
- Exchange
- LWLG Nasdaq
- NKTR Nasdaq
- Market Cap
- LWLG 126.0M
- NKTR 108.3M
- IPO Year
- LWLG N/A
- NKTR 1994
- Fundamental
- Price
- LWLG $1.24
- NKTR $24.54
- Analyst Decision
- LWLG
- NKTR Strong Buy
- Analyst Count
- LWLG 0
- NKTR 6
- Target Price
- LWLG N/A
- NKTR $77.50
- AVG Volume (30 Days)
- LWLG 1.9M
- NKTR 4.4M
- Earning Date
- LWLG 08-08-2025
- NKTR 08-07-2025
- Dividend Yield
- LWLG N/A
- NKTR N/A
- EPS Growth
- LWLG N/A
- NKTR N/A
- EPS
- LWLG N/A
- NKTR N/A
- Revenue
- LWLG $88,105.00
- NKTR $87,248,000.00
- Revenue This Year
- LWLG N/A
- NKTR N/A
- Revenue Next Year
- LWLG N/A
- NKTR N/A
- P/E Ratio
- LWLG N/A
- NKTR N/A
- Revenue Growth
- LWLG 24.23
- NKTR N/A
- 52 Week Low
- LWLG $0.79
- NKTR $6.48
- 52 Week High
- LWLG $4.23
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- LWLG 53.06
- NKTR 68.99
- Support Level
- LWLG $1.19
- NKTR $8.27
- Resistance Level
- LWLG $1.38
- NKTR $37.38
- Average True Range (ATR)
- LWLG 0.10
- NKTR 3.48
- MACD
- LWLG -0.01
- NKTR 1.42
- Stochastic Oscillator
- LWLG 23.68
- NKTR 56.31
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.